Whitehawk Therapeutics, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +1,846.6% | -92.3% | +1,258.6% | +60.1% | +6.7% | -72.5% | |
| – | +35.6% | +31.1% | +72.8% | +52.2% | +4.5% | -98.6% | |
| – | – | – | – | – | – | – | |
| – | +35.6% | +31.1% | +66.0% | +49.8% | +4.3% | +78.3% | |
| – | +14.4% | +772.7% | +117.0% | +10.9% | -17.5% | -18.8% | |
| – | +14.4% | +4,269.0% | -52.6% | +1.5% | -11.6% | +206.7% | |
| – | – | – | – | – | – | – | |
| – | +871.0% | -18.4% | -65.4% | +0.4% | -33.3% | -100.0% | |
| – | – | – | – | – | – | – | |
| – | +53.8% | +0.0% | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.